Posts in About patientMpower
patientMpower Starts New Trial in Renal Dialysis

We are delighted to have recently started a new trial with the patientMpower platform for renal dialysis. Together with researchers in Beaumont Hospital, Dublin, Ireland, we are examining how the patientMpower app can help people undergoing renal dialysis to better manage their fluid weight gain between dialysis sessions.  The trial protocol is available on

Read More
Endorsement by EU-IPFF

We are delighted that our app for IPF has been recently been endorsed by the EU-IPFF.
The European Idiopathic Pulmonary Fibrosis and Related Disorders Federation (EU-IPFF) is a non-profit organization that brings together European national patient associations committed to defending their vision of equal access to treatment and care for all IPF patients. They aim to serve as a trusted resource for the IPF community by raising awareness, providing disease education, advancing care, and supporting research for IPF whilst defending the interests of IPF patients at European level.

Read More
Visit us at #LUNGFORCE Expo in Cherry Hill, NJ, March 27th!

patientMpower for pulmonary fibrosis and lung transplant enables you to keep track of everything relating to your lung health, empowering you to get the best possible outcomes from your treatment and care. Our free app connects to devices you can use at home  to track spirometry, pulse oximetry, medication reminders, air quality updates and step counter recording.

Read More
patientMpower speaks out for Lung Fibrosis patients across the UK

On behalf of patients across the UK living with Idiopathic Pulmonary Fibrosis (IPF), patientMpower expressed disappointment at NICE’s decision to restrict the use of the antifibrotic pirfenidone (Esbriet) to patients with moderate to severe forms of the disease. NICE recently issued final guidance that pirfenidone is recommended as a treatment option for IPF only if the patient has a forced vital capacity (FVC) between 50% and 80% predicted.

Read More
patientMpower one of the winners of $1,000,000 IPF Catalyst Challenge

Three Lakes Partners, a venture philanthropy committed to ending Idiopathic Pulmonary Fibrosis (IPF), named Advanced Interactive Response Systems (AIRS), Owlstone Medical and patientMpower the winners of its $1,000,000 IPF Catalyst Challenge last night during a live finalist pitch event at MATTER’s Chicago headquarters. Level Ex was honored with the event’s Audience Choice Award.

Read More
patientMpower presents at Artificial Intelligence Health2.0 Meetup hosted by Google & Verily

patientMpower presented at the Artificial Intelligence Health2.0 Dublin chapter meetup hosted in January by Google and Verily.  Eamonn Costello outlined the Machine Learning process patientMpower is employing in ‘cleaning’ and ‘training’ a real world spirometry data set.  These data are contained within patientMpower’s “digital biobankTM“, which contains over 3 million Idiopathic Pulmonary Fibrosis (IPF) data points including thousands of Forced Vital Capacity (FVC) data points.

Read More